Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients
The current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory coronavirus 2 (SARS-CoV-2), remains a major public health problem across the globe, despite the availability of vaccines (Hamed et al., 2021). Consequently, there is a continuing need for effective pharmacological therapies that reduce the morbidity and mortality of patients with COVID-19.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Carlos Diaz-Arocutipa, Beatriz Melgar-Talavera, Ángel Alvarado-Yarasca, María M. Saravia-Bartra, Pedro Cazorla, Iván Belzusarri, Adrian V. Hernandez Source Type: research
More News: Cholesterol | Coronavirus | COVID-19 | Infectious Diseases | International Medicine & Public Health | Pandemics | Respiratory Medicine | SARS | Statin Therapy | Vaccines